Total Payments
$3,178
2024 Payments
$333.19
Companies
24
Transactions
51
Medicare Patients
1,564
Medicare Billing
$225,941
Payment Breakdown by Category
Food & Beverage$3,178 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,178 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $313.83 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $270.59 | 4 | $0 (2023) |
| Eisai Inc. | $245.22 | 2 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $231.97 | 6 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $220.88 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $187.63 | 4 | $0 (2022) |
| Exact Sciences Corporation | $165.72 | 5 | $0 (2024) |
| Shire North American Group Inc | $145.47 | 2 | $0 (2019) |
| Amgen Inc. | $139.58 | 3 | $0 (2023) |
| Allergan, Inc. | $128.05 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $333.19 | 9 | Exact Sciences Corporation ($165.72) |
| 2023 | $164.20 | 3 | Ferring Pharmaceuticals Inc. ($123.68) |
| 2022 | $625.53 | 9 | Takeda Pharmaceuticals U.S.A., Inc. ($209.45) |
| 2021 | $184.93 | 4 | Eisai Inc. ($120.22) |
| 2020 | $326.95 | 3 | Eisai Inc. ($125.00) |
| 2019 | $541.05 | 7 | Stryker Corporation ($171.28) |
| 2018 | $701.56 | 11 | AstraZeneca Pharmaceuticals LP ($126.98) |
| 2017 | $300.33 | 5 | Stryker Corporation ($142.55) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: Oncology | ||||||
| 12/06/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.98 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $64.27 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Oncology | ||||||
| 06/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $103.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: Oncology | ||||||
| 03/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes | ||||||
| 11/01/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $123.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/01/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Cardiology | ||||||
| 05/03/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $97.91 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/30/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: IMMUNOLOGY | ||||||
| 08/03/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $117.39 | General |
| Category: Cardio-renal | ||||||
| 06/03/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: IMMUNOLOGY | ||||||
| 04/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $89.60 | General |
| Category: DIABETES | ||||||
| 04/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $111.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/29/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2021 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: IMMUNOLOGY | ||||||
| 03/03/2021 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $120.22 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 343 | 616 | $136,342 | $53,872 |
| 2022 | 6 | 329 | 509 | $126,178 | $43,888 |
| 2021 | 9 | 456 | 692 | $165,797 | $60,450 |
| 2020 | 7 | 436 | 872 | $107,021 | $67,732 |
Total Patients
1,564
Total Services
2,689
Medicare Billing
$225,941
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 232 | $36,026 | $20,467 | 56.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 133 | $43,044 | $12,725 | 29.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 53 | $20,634 | $7,390 | 35.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 38 | 39 | $11,394 | $3,598 | 31.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 51 | $9,324 | $3,244 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 48 | $7,834 | $3,038 | 38.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 11 | 44 | $3,290 | $1,736 | 52.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $4,796 | $1,673 | 34.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 78 | 180 | $56,103 | $14,964 | 26.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 67 | 69 | $25,929 | $11,088 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 113 | $15,477 | $8,530 | 55.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 41 | 42 | $11,760 | $3,589 | 30.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 32 | 60 | $10,485 | $3,471 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 45 | $6,425 | $2,246 | 35.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 112 | 261 | $77,892 | $22,138 | 28.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 75 | 77 | $27,622 | $12,666 | 45.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 73 | 114 | $15,369 | $9,495 | 61.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 54 | 55 | $14,828 | $4,815 | 32.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 73 | $9,912 | $4,096 | 41.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 42 | 63 | $10,507 | $3,719 | 35.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 17 | $4,663 | $1,900 | 40.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 17 | 17 | $3,639 | $1,010 | 27.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 15 | $1,365 | $611.78 | 44.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 170 | 532 | $58,291 | $43,706 | 75.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 78 | 116 | $16,812 | $6,923 | 41.2% |
About Dr. John Miskovsky, MD
Dr. John Miskovsky, MD is a Internal Medicine healthcare provider based in Pawtucket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1497743330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Miskovsky, MD has received a total of $3,178 in payments from pharmaceutical and medical device companies, with $333.19 received in 2024. These payments were reported across 51 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,178).
As a Medicare-enrolled provider, Miskovsky has provided services to 1,564 Medicare beneficiaries, totaling 2,689 services with total Medicare billing of $225,941. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Pawtucket, RI
- Active Since 10/13/2005
- Last Updated 03/05/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497743330
Products in Payments
- GLASSIA (Biological) $253.57
- Lenvima (Drug) $245.22
- BEVESPI AEROSPHERE (Drug) $241.54
- LifeVest (Device) $220.88
- XARELTO (Drug) $175.98
- ASNIS (Device) $171.28
- Cologuard Collection Kit (Device) $165.72
- HOFFMANN (Device) $142.55
- Repatha (Biological) $139.58
- UBRELVY (Drug) $130.04
- DARZALEX (Biological) $125.00
- Tymlos (Biological) $124.79
- ARALAST (Biological) $123.87
- REBYOTA (Biological) $123.68
- Kerendia (Drug) $117.39
- Santyl (Drug) $116.72
- Epclusa (Drug) $116.57
- VOQUEZNA (Drug) $103.63
- JARDIANCE (Drug) $89.60
- ANORO (Drug) $32.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pawtucket
Jeffrey Baron, Md, MD
Internal Medicine — Payments: $25,398
Internal Medicine $25,398
Omeed Sani, M.d, M.D
Internal Medicine — Payments: $16,518
Internal Medicine $16,518
Muhammad Ehtisham, M.d, M.D
Internal Medicine — Payments: $8,398
Internal Medicine $8,398
Rafael Liporaci Lucena, Md, MD
Internal Medicine — Payments: $6,813
Internal Medicine $6,813
Dr. Vinit Joseph Gilvaz, Md, MD
Internal Medicine — Payments: $3,785
Internal Medicine $3,785
Amber Gul, M.d, M.D
Internal Medicine — Payments: $3,620
Internal Medicine $3,620